Evaluation of [18F]Nifene biodistribution and dosimetry based on whole-body PET imaging of mice

Nuclear Medicine and Biology

Volumn 40, Issue 2, 2013, Pages 289-294

  Constantinescu, Cristian C ^a   Garcia, Adriana ^a   Mirbolooki, M Reza ^a   Pan, Min Liang ^a   Mukherjee, Jogeshwar ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

4 2; 18F Nifene; Biodistribution; Dosimetry; PET; Preclinical

Indexed keywords

NIFENE F 18; TRACER; UNCLASSIFIED DRUG; DIAGNOSTIC AGENT; NIFENE; PYRIDINE DERIVATIVE; PYRROLE DERIVATIVE;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; BLADDER; BONE; BRAIN; DOSIMETRY; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG HALF LIFE; FEMALE; HEART; HIGH RESOLUTION COMPUTER TOMOGRAPHY; IN VIVO STUDY; KIDNEY; LARGE INTESTINE; LIVER; LUNG; MALE; MEAN RESIDENCE TIME; MOUSE; NONHUMAN; PANCREAS; RADIATION DOSE; RADIOACTIVITY; SMALL INTESTINE; SPLEEN; STOMACH; TESTIS; THYMUS; UTERUS; WHOLE BODY PET; ADULT; ANIMAL; COMPUTER ASSISTED TOMOGRAPHY; HUMAN; IMAGE QUALITY; POSITRON EMISSION TOMOGRAPHY; RADIOMETRY; SPECIES DIFFERENCE; TISSUE DISTRIBUTION; WHOLE BODY IMAGING;

ADULT; ANIMALS; FEMALE; HUMANS; MALE; MICE; PHANTOMS, IMAGING; POSITRON-EMISSION TOMOGRAPHY; PYRIDINES; PYRROLES; RADIATION DOSAGE; RADIOMETRY; SPECIES SPECIFICITY; TISSUE DISTRIBUTION; TOMOGRAPHY, X-RAY COMPUTED; WHOLE BODY IMAGING;

MLCS; MLOWN;

EID: 84872918352     PISSN: 09698051     EISSN: 18729614     Source Type: Journal    
DOI: 10.1016/j.nucmedbio.2012.11.004     Document Type: Article

References (24)

1. Wu J., Ishikawa M., Zhang J., Hashimoto K. Brain imaging of nicotinic receptors in Alzheimer's disease. Int J Alzheimers Dis 2010, 2010:548913.
2. Kendziorra K., Wolf H., Meyer P.M., Barthel H., Hesse S., Becker G.A., et al. Decreased cerebral alpha4beta2* nicotinic acetylcholine receptor availability in patients with mild cognitive impairment and Alzheimer's disease assessed with positron emission tomography. Eur J Nucl Med Mol Imaging 2011, 38:515-525.
3. Kadir A., Almkvist O., Wall A., Langstrom B., Nordberg A. PET imaging of cortical 11C-nicotine binding correlates with the cognitive function of attention in Alzheimer's disease. Psychopharmacology (Berl) 2006, 188:509-520.
4. Sihver W., Langstrom B., Nordberg A. Ligands for in vivo imaging of nicotinic receptor subtypes in Alzheimer brain. Acta Neurol Scand Suppl 2000, 176:27-33.
5. Valette H., Bottlaender M., Dolle F., Guenther I., Fuseau C., Coulon C., et al. Imaging central nicotinic acetylcholine receptors in baboons with [18F]fluoro-A-85380. J Nucl Med 1999, 40:1374-1380.
6. Bucerius J., Joe A.Y., Schmaljohann J., Gundisch D., Minnerop M., Biersack H.J., et al. Feasibility of 2-deoxy-2-[18F]fluoro-D-glucose- A85380-PET for imaging of human cardiac nicotinic acetylcholine receptors in vivo. Clin Res Cardiol 2006, 95:105-109.
7. Brasic J.R., Cascella N., Kumar A., Zhou Y., Hilton J., Raymont V., et al. Positron emission tomography experience with 2-[(1)F]fluoro-3-(2(S)-azetidinylmethoxy)pyridine (2-[(1)F]FA) in the living human brain of smokers with paranoid schizophrenia. Synapse 2012, 66:352-368.
8. Le Foll B., Chefer S.I., Kimes A.S., Shumway D., Stein E.A., Mukhin A.G., et al. Baseline expression of alpha4beta2* nicotinic acetylcholine receptors predicts motivation to self-administer nicotine. Biol Psychiatry 2009, 65:714-716.
9. Mukhin A.G., Kimes A.S., Chefer S.I., Matochik J.A., Contoreggi C.S., Horti A.G., et al. Greater nicotinic acetylcholine receptor density in smokers than in nonsmokers: a PET study with 2-18F-FA-85380. J Nucl Med 2008, 49:1628-1635.
10. Li J.G., Lehr M., Liu-Chen L.Y., Woodruff-Pak D.S. Nicotinic acetylcholine receptors and modulation of learning in 4- and 27-month-old rabbits. Neuropsychopharmacology 2008, 33:2820-2830.
11. Bieszczad K.M., Kant R., Constantinescu C.C., Pandey S.K., Kawai H.D., Metherate R., et al. Nicotinic acetylcholine receptors in rat forebrain that bind (18) F-nifene: relating PET imaging, autoradiography, and behavior. Synapse 2012, 66:418-434.
12. Horti A.G., Scheffel U., Koren A.O., Ravert H.T., Mathews W.B., Musachio J.L., et al. 2-[18F]Fluoro-A-85380, an in vivo tracer for the nicotinic acetylcholine receptors. Nucl Med Biol 1998, 25:599-603.
13. Vaupel D.B., Stein E.A., Mukhin A.G. Quantification of alpha4beta2* nicotinic receptors in the rat brain with microPET and 2-[18F]F-A-85380. Neuroimage 2007, 34:1352-1362.
14. Pichika R., Easwaramoorthy B., Collins D., Christian B.T., Shi B., Narayanan T.K., et al. Nicotinic alpha4beta2 receptor imaging agents: part II. Synthesis and biological evaluation of 2-[18F]fluoro-3-[2-((S)-3-pyrrolinyl)methoxy]pyridine (18F-nifene) in rodents and imaging by PET in nonhuman primate. Nucl Med Biol 2006, 33:295-304.
15. Hillmer A.T., Wooten D.W., Moirano J.M., Slesarev M., Barnhart T.E., Engle J.W., et al. Specific alpha4beta2 nicotinic acetylcholine receptor binding of [F-18]nifene in the rhesus monkey. Synapse 2011, 65:1309-1318.
16. Kant R., Constantinescu C.C., Parekh P., Pandey S.K., Pan M.L., Easwaramoorthy B., et al. Evaluation of F-nifene binding to alpha4beta2 nicotinic receptors in the rat brain using microPET imaging. EJNMMI Res 2011, 1:6.
17. Keenan M.A., Stabin M.G., Segars W.P., Fernald M.J. RADAR realistic animal model series for dose assessment. J Nucl Med 2010, 51:471-476.
18. Stabin M.G., Sharkey R.M., Siegel J.A. RADAR commentary: evolution and current status of dosimetry in nuclear medicine. J Nucl Med 2011, 52:1156-1161.
19. Kirschner A.S., Ice R.D., Beierwaltes W.H. Radiation-dosimetry of i-131-19-iodocholesterol - pitfalls of using tissue concentration data - reply. J Nucl Med 1975, 16:248-249.
20. Ma Y., Smith D., Hof P.R., Foerster B., Hamilton S., Blackband S.J., et al. In vivo 3D digital atlas database of the adult C57BL/6J mouse brain by Magnetic resonance microscopy. Front Neuroanat 2008, 2:1.
21. Bottlaender M., Valette H., Roumenov D., Dolle F., Coulon C., Ottaviani M., et al. Biodistribution and radiation dosimetry of 18F-fluoro-A-85380 in healthy volunteers. J Nucl Med 2003, 44:596-601.
22. Verschuer J.D., Towson J., Eberl S., Katsifis A., Henderson D., Lam P., et al. Radiation dosimetry of the translocator protein ligands [18F]PBR111 and [18F]PBR102. Nucl Med Biol 2012, 39:742-753.
23. Constantinescu C.C., Sevrioukov E., Garcia A., Pan M.-L., Mukherjee J. Evaluation of [18F]Mefway biodistribution and dosimetry based on whole-body PET imaging of mice. Mol Imaging Biol 2012, [Epub ahead of print].
24. Food and Drug Administration Title 21 CFR 361.1 Radioactive Drugs for Certain Research Uses 2011, 325-330. National Archives and Records Administration, Office of the Federal Register, Washington DC.